The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
companies founded by graduates and faculty in the last 10 years
locations
of all universities in the world*
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSAs Seen in nocamels.com
A medical breakthrough now allows doctors to freeze early-stage breast tumors – with no surgery, no scarring, no general anesthetic and no tissue removal.
The entire procedure can take as little as 40 minutes. Patients can go straight home after its done, and are spared the painful recovery process.
The idea of using an extremely cold liquid to freeze and destroy abnormal tissue – or cryoablation – isn’t new. Doctors have been doing it in hospitals for the last 30 years.
But IceCure Medical, an Israeli startup, has developed technology that allows physicians to perform the procedure at their own office, with no need for hospitalization.
IceCure Medical, an Israeli startup, has developed technology that allows physicians to perform the procedure at their own office, with no need for hospitalization. IceCure Medical CTO and Chief Engineer Nir Berzak and IVP of Quality Assurance Shay Levav are both alumni of the Technion.
by
nocamels.com (opens in a new tab)
on
January 30, 2023
Learn how the revolutionary IceCure Medical's freeze method effectively eliminates tumors in just minutes without invasive procedures.
1 min
X (opens in a new tab) / Facebook (opens in a new tab) / LinkedIn (opens in a new tab) / Email / Copy Link
Bringing these diverse fields together under one roof is intended to shorten the journey from discovery to application, creating an environment where medical needs can spark new research and promising innovations can move more quickly toward the patients who need them. “The combination of a research hospital and a technological university provides the entire value […]
Prof. Hossam Haick of the Technion – Israel Institute of Technology, one of Israel’s most successful scientists, is really a frustrated karate fighter. As a boy in Nazareth, he joined a karate class and seemed to have found his calling. “I was incredibly competitive,” he says. “I went from one achievement to the next.” But […]
The Nobel Assembly at Karolinska Institutet announced Monday that professors Karl Deisseroth, Peter Hegemann, and Georg Nagel were awarded the 2026 Nobel Prize in Medicine, with two of the three laureates having received the Technion-Israel Institute of Technology Harvey Prize. Prof. Deisseroth of the Howard Hughes Medical Institute and Stanford University, USA, and Prof. Hegemann […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.